This phenomenon of reduced cells’ response to insulin leads to hyperinsulinemia, which occurs due to genetic polymorphisms; tyrosine phosphorylation of the insulin receptor, insulin receptor proteins, PIP-3 kinase; or abnormalities of GLUT 4 function; and/or environmental factors [157,158,159,160]. The gene discussed is SLC2A4; the disease is Hyperinsulinemia.